Glial IL-33 signaling through an ST2-to-CXCL12 pathway in the spinal cord contributes to morphine-induced

Xue-Ming Hu1, Wei Yang1, Meng-Ting Zhang1,2

  • 1Department of Integrative Medicine and Neurobiology, School of Basic Medical Science, Institutes of Integrative Medicine, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Institutes of Brain Science, Shanghai Medical College, Fudan University, Shanghai 200032, China.

Science Signaling
|September 13, 2021
PubMed

Insights

Targeting interleukin-33 (IL-33) and its receptor ST2 in the spinal cord can prevent opioid-induced hyperalgesia and tolerance, offering a new strategy for effective chronic pain management.

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Opioids like morphine are effective for severe pain but can cause hyperalgesia and tolerance, limiting long-term use.
  • The molecular mechanisms behind morphine-induced hyperalgesia and tolerance are not fully understood.
  • Interleukin-33 (IL-33) and its receptor ST2 are implicated in inflammatory and pain pathways.

Purpose of the Study:

  • To investigate the role of interleukin-33 (IL-33) and its receptor ST2 in morphine-induced hyperalgesia and analgesic tolerance.
  • To elucidate the molecular pathways involved in IL-33/ST2-mediated opioid side effects.

Main Methods:

  • Repeated subcutaneous morphine injections in mice.
  • Measurement of IL-33 and ST2 expression in the spinal cord.
  • Pharmacological inhibition and genetic knockdown/knockout of IL-33 and ST2.
  • Assessment of astroglial activation, synaptic transmission, and pain behaviors.
  • Analysis of the TRAF6-JNK-CXCL12 pathway.

Main Results:

  • Morphine treatment increased IL-33 and ST2 abundance in spinal cord astrocytes and oligodendrocytes.
  • Inhibition or genetic deletion of IL-33 or ST2 attenuated morphine-induced hyperalgesia and tolerance.
  • IL-33/ST2 signaling promoted astroglial activation and enhanced excitatory synaptic transmission.
  • A pathway involving TRAF6, JNK, and CXCL12 in astrocytes mediated IL-33's effects.

Conclusions:

  • Spinal IL-33/ST2 signaling is a key mediator of morphine-induced hyperalgesia and analgesic tolerance.
  • Targeting the IL-33-ST2 pathway, potentially via TRAF6 and CXCL12, offers a promising strategy for sustained opioid analgesia in chronic pain.
  • This research opens new avenues for managing chronic pain by enhancing the efficacy and durability of opioid treatments.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
954
Nociception01:44

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
30.9K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
2.5K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.5K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
482
Pain01:20

Pain

Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...
867